As your viral vector CDMO partner, we have the experience, expertise, and capabilities to guide your program through development and into the clinical trial. With 14+ years of experience, our Viral Vector Services (VVS) team has developed more than 60 different viral vectors, supported 10 manufacturing platforms, and completed over 150 lots of clinical trial material.
Let us put our expertise to work to advance your viral vector product therapy into the clinic and beyond. Contact us to learn how we can help you with your viral vector development project.
Download the “Leading Viral Vector CDMO Services for Cell and Gene Therapies” brochure to learn more about our end-to-end viral vector service capabilities.